4//SEC Filing
Feike Jeffrey L. 4
Accession 0001062993-24-003491
CIK 0001860871other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:26 PM ET
Size
4.9 KB
Accession
0001062993-24-003491
Insider Transaction Report
Form 4
Feike Jeffrey L.
Director
Transactions
- Award
Common Stock
2024-02-14+581,771→ 581,771 total
Footnotes (1)
- [F1]On February 14, 2024, pursuant to that certain Agreement and Plan of Merger, dated as of June 28, 2023, by and among the Issuer, Semper Merger Sub, Inc., and Tevogen Bio Inc ("Tevogen"), each issued and outstanding share of common stock of Tevogen was automatically cancelled and converted into approximately 4.8481 shares of the common stock of the Issuer.
Issuer
Tevogen Bio Holdings Inc.
CIK 0001860871
Entity typeother
Related Parties
1- filerCIK 0002011766
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 5:26 PM ET
- Size
- 4.9 KB